The RIQAS HIV/Hepatitis EQA programme is designed to monitor the performance of tests used to detect HIV/Hepatitis antibodies and specific antigens. All samples are conveniently supplied liquid ready-to-use and are suitable for qualitative methods of analysis.
- Liquid ready-to-use
- 100% human serum
- Monthly reporting (12 samples per bi-annual distribution)
- Submit results and view reports online via RIQAS.Net
- Suitable for both quantitative and qualitative methods of analysis
- Cycle Starts – July 2025
Not accredited to ISO/IEC 17043
Cat No | Kit Size | Frequency | Parameters | |
---|---|---|---|---|
RQ9151 | 12 x 1.8ml (2 samples to be tested per month. Samples shipped 2 times per year) | Monthly reporting (1 x 12 month cycle) | 10 + 6 Pilots | |
Parameters
- Anti-HIV-1
- Anti-HCV
- Anti-HTLV-II
- HBsAg
- Anti-HIV-2
- Anti-HBC (IgM)*
- Anti-HTLV-1&2 (combined)
- Anti-HIV-1&2 (combined)
- Anti-HTLV-I
- Anti-CMV
- Anti-HAV IgG
- Anti-HAV IgM*
- Anti-HAV (Total)*
- Anti-HBc (Total)
- Anti-HBe (Total)*
- Anti-HBs (Total)*
- P24*
*Pilot parameter.
Please note, product availability may vary country to country.